Phospholipase D activity is elevated in hepatitis C virus core protein-transformed NIH3T3 mouse fibroblast cells

Experimental and Molecular Medicine

Volumn 36, Issue 5, 2004, Pages 454-460

  Kim, Joonmo ^a   Choi, Bok Hee ^b   Jang, Kyung Lib ^c   Min, Do Sik ^c  

^a The Catholic University of Korea   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

HCV core protein; p38; PKC; PLD

Indexed keywords

CORE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE D;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL STIMULATION; CELL TRANSFORMATION; ENZYME ACTIVITY; FIBROBLAST; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HYDROPHOBICITY; LIVER CELL CARCINOMA; LIVER DISEASE; MITOGENESIS; MOUSE; NONHUMAN; PROTEIN STRUCTURE; TISSUE SPECIFICITY; VIRUS CORE;

ANIMALIA; HEPATITIS C VIRUS;

EID: 9344249541     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2004.57     Document Type: Article

References (31)

1. Ahn BH, Kim SY, Kim EH, Choi KS, Kwon TK, Lee YH, Chang JS, Kim MS, Jo YH, Min DS. Transmodulation between phospholipase D and c-Src enhances cell proliferation. Mol Cell Biol 2003;23:3103-15
2. Banno Y, Tamiya-Koizumi K, Oshima H, Morikawa A, Yoshida S, Nozawa Y. Nuclear ADP-ribosylation factor (ARF)- and oleate-dependent phospholipase D (PLD) in rat liver cells. Increases of ARF-dependent PLD activity in regenerating liver cells. J Biol Chem 1997;272:5208-13
3. Chang J, Yang SH, Cho YG, Hwang SB, Hahn YS, Sung YC. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol 1998;72:3060-5
4. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ, Frohman MA. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 1997;7:191-01
5. Erhardt A, Hassan M, Heintges T, Haussinger D. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002;292:272-84
6. Fiucci GM, Czarny Y, Lavie Y, Zhao D, Berse B, Blusztajn JK, Liscovitch M. Changes of phospholipase D isoform activity and expression in multidrug-resistant human cancer cells. Int J Cancer 2000;85:882-8
7. Frankel P, Ramos M, Flom J, Bychenok S, Joseph T, Kerkhoff E, Rapp UR, Feig LA, Foster DA. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells. Biochem Biophys Res Commun 1999;255:502-7
8. Hammond SM, Jenco JM, Nakashima S, Cadwallader K, Gu Q, Cook S, Nozawa Y, Prestwich GD, Frohman MA, Morris, AJ. Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-α. J Biol Chem 1997;272:3860-8
9. Han HJ, Jung EY, Lee WJ, Jang KL. Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Lett 2002;518:169-72
10. Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A, Ueki T, Hirano T, Yamamoto H, Fujimoto J, Okamoto E, Hayashi N, Hori M. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 1998;27:951-8
11. Jiang YW, Song J, Zhang Q, Foster DA. Phosphatidylcholine-specific phospholipase D activity is elevated in v-Fps-transformed cells. Biochem Biophys Res Commun 1994;203: 1195-03
12. Jung EY, Lee MN, Yang HY, Yu D, Jang KL. The repressive activity of hepatitis C virus core protein on the transcription of p21 (waf1) is regulated by protein kinase A-mediated phosphorylation. Virus Res 2001;79:109-15
13. Jung, EY, Kang HK, Chang J, Yu DY, Jang KL, Cooperative transformation of murine fibroblast NIH3T3 cells by hepatitis C virus core protein and hepatitis B virus X protein. Virus Res 2003;94:79-84
14. Kim KO, Lee KH, Kim YH, Park SK, Han JS. Anti-apoptotic role of phospholipase D isozymes in the glutamate-induced cell death. Exp Mol Med 2003;35:38-45
15. Koike K, Tsutsumi K, Fujie H, Shintani Y, Kyoji M. Molecular mechanism of viral hepatocarcinogenesis. Oncology 2002; 62:29-37
16. Lee MY, Jo YJ, Chun, Chung JW, Kim MS, Min DS. Immunohistochemical localization of phospholipase D1 in rat central nervous system. Brain Res 2000;864:52-9
17. Liscovitch M, Czamy M, Fiucci G, Tang X. Phospholipase D: molecular and cell biology of a novel gene family. Biochem J 2000;345:401-15
18. Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 1999;73:4713-20
19. Min DS, Kwon TK, Park WS, Chang JS, Park SK, Ahn BH, Ryoo ZT, Lee YH, Lee YS, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, Jo YH. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 2001;22:1641-7
20. Min DS, Shin EY, Kim EG. The p38 mitogen-activated protein kinase is involved in stress-induced phospholipase D activation in vascular smooth muscle cells. Exp Mol Med 2002;34:38-46
21. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7
22. Ray RB, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 1997;272:10983-6
23. Ray RB, Ray R. Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol Lett 2001;202:149-56
24. Saito T, Miyamura A, Ohbayashi H, Harada T, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Choo QL, Houghton M, Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547-9
25. Shiravastava A, Manna SK, Ray R. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol 1998;72:9722-8
26. Steed PM, Chow AHM. Intracellular signaling by phospholipase D as therapeutic target. Curr Pharmaceu Biotech 2001;2:241-56
27. Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi H, Matsuura Y, Koike K, Miyamura T. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 2003;38:820-8.
28. Uchida T. Pathology of hepatitis C. Intervirology 1994;37:126-32
29. Uchida N, Okamura S, Nagamachi Y. Increased phospholipase D activity in human breast cancer. J Cancer Res Clin Oncol 1997;13:280-5
30. Uchida N, Okamura S, Kuwano H. Phospholipase D activity in human gastric carcinoma. Anticancer Res 1999;19:671-6
31. Zhao Y, Ehara H, Akao Y, Shamato M, Nakagawa Y, Banno Y, Deguchi T, Ohishi N, Yaki K, Nozawa Y. Increased activity and intracellular expression of phospholipase D in human renal cancer. Biochem Biophys Res Commun 2000;278:140-3